ATE493137T1 - Strontiumhaltige verbindungen zur verwendung bei prävention oder behandlung nekrotisierender knochenkrankheiten - Google Patents

Strontiumhaltige verbindungen zur verwendung bei prävention oder behandlung nekrotisierender knochenkrankheiten

Info

Publication number
ATE493137T1
ATE493137T1 AT05706802T AT05706802T ATE493137T1 AT E493137 T1 ATE493137 T1 AT E493137T1 AT 05706802 T AT05706802 T AT 05706802T AT 05706802 T AT05706802 T AT 05706802T AT E493137 T1 ATE493137 T1 AT E493137T1
Authority
AT
Austria
Prior art keywords
bone
prevention
treatment
containing compounds
strontium containing
Prior art date
Application number
AT05706802T
Other languages
German (de)
English (en)
Inventor
Christian Hansen
Henrik Nilsson
Stephan Christgau
Henry Bone
Original Assignee
Osteologix As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteologix As filed Critical Osteologix As
Priority claimed from PCT/DK2005/000140 external-priority patent/WO2005082385A1/en
Application granted granted Critical
Publication of ATE493137T1 publication Critical patent/ATE493137T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05706802T 2004-02-26 2005-02-28 Strontiumhaltige verbindungen zur verwendung bei prävention oder behandlung nekrotisierender knochenkrankheiten ATE493137T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54852904P 2004-02-26 2004-02-26
DKPA200400313 2004-02-26
PCT/DK2005/000140 WO2005082385A1 (en) 2004-02-26 2005-02-28 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions

Publications (1)

Publication Number Publication Date
ATE493137T1 true ATE493137T1 (de) 2011-01-15

Family

ID=34956357

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05706802T ATE493137T1 (de) 2004-02-26 2005-02-28 Strontiumhaltige verbindungen zur verwendung bei prävention oder behandlung nekrotisierender knochenkrankheiten

Country Status (6)

Country Link
JP (1) JP4839302B2 (da)
AT (1) ATE493137T1 (da)
DE (1) DE602005025616D1 (da)
DK (1) DK1732575T3 (da)
PT (1) PT1732575E (da)
SI (1) SI1732575T1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2809286C (en) * 2009-09-11 2018-02-13 Straxcorp Pty Ltd Method and system for image analysis of selected tissue structures

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0737471A3 (fr) * 1995-04-10 2000-12-06 L'oreal Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
WO2002080955A1 (en) * 2001-03-22 2002-10-17 Barnes-Jewish Hospital Stimulation of osteogenesis using rank ligand fusion proteins
NO20014746D0 (no) * 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
US20040258730A1 (en) * 2001-11-12 2004-12-23 Yasuhiko Tabata Persistent filmy preparation for topical administration containing prostglandin derivative

Also Published As

Publication number Publication date
DE602005025616D1 (de) 2011-02-10
PT1732575E (pt) 2011-03-23
JP2007523916A (ja) 2007-08-23
SI1732575T1 (sl) 2011-05-31
JP4839302B2 (ja) 2011-12-21
DK1732575T3 (da) 2011-03-28

Similar Documents

Publication Publication Date Title
EP1851237A4 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING BONE DISORDERS
ATE395871T1 (de) Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen
DE602007011908D1 (de) Verwendung von gpr119-rezeptoragonisten zur vermehrung der knochenmasse und zur behandlung von osteoporose sowie kombinationstherapie dafür
EP1916964A4 (en) IMPLANTS AND METHODS FOR THE REPAIR, REPLACEMENT AND TREATMENT OF JOINT DISEASES
DE602006018583D1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
EP2001293A4 (en) USE OF CÉTOGENIC COMPOUNDS FOR THE TREATMENT OF AGE-RELATED COGNITIVE DISORDERS
DE60324777D1 (de) Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
ATE440866T1 (de) Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten
ATE413385T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
EP1991274A4 (en) METHOD OF TREATMENT, PROPHYLAXIS AND DIAGNOSIS OF BONE PATHOLOGIES
EP2010184A4 (en) IMPLANTS FOR THE TREATMENT OF DOPAMINE-ASSOCIATED CONDITIONS
DE602005021970D1 (de) Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen
DE602004002585D1 (de) VERWENDUNG EINER PHARMAZEUTISCHEN FORMULIERUNG ENTHALTEND MILCHSÄURE ODER LAKTAT UND kALIUM ZUR BEHANDLUNG VON HIRNÖDEM UND VERLETZUNGEN DES GEHIRNS
EP2135858A4 (en) COMPOSITION FOR TREATING INFECTIOUS DISEASES
ATE447551T1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
DE502005010499D1 (de) Implantat zur Behandlung von Fettsucht
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
EP1556085A4 (en) COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
ATE446754T1 (de) Verbindungen zur behandlung von schizophrenie und/oder glucoregulatorische auffälligkeiten
DE602006009899D1 (de) Verwendung von oxycodon zur behandlung von viszeralem schmerz
DE602004019576D1 (de) Zur behandlung von schmerzen geeignete piperazine
DE602004022035D1 (de) Verwendung von pthalide derivativen zur behandlung
EP1905452A4 (en) AGENT FOR THE PREVENTION OR TREATMENT OF GLAUCOMA
DE502006007982D1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1732575

Country of ref document: EP